Best Stocks : Mattel, Inc. (NASDAQ:MAT), Weatherford International plc (NYSE:WFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), General Electric Company (NYSE:GE), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

On Oct 17, Mattel, Inc. (NASDAQ:MAT), posted profit that trailed analysts’ estimates as sales of Barbie dolls dropped for a fourth straight quarter. Third-quarter net income shrank 22 percent to $331.8 million, or 97 cents a share, from $422.8 million, or $1.21, the El Segundo, California-based company said today in a statement. Analysts had predicted $1.02 a share, on average, based on 12 estimates compiled … Continue reading Best Stocks : Mattel, Inc. (NASDAQ:MAT), Weatherford International plc (NYSE:WFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), General Electric Company (NYSE:GE), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

Trader’s Watch List : Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Intercontinental Exchange, Inc. (NYSE:ICE), Kearny Financial Corp. (NASDAQ:KRNY), Kimberly-Clark Corporation (NYSE:KMB),

Equities research analysts at Credit Agricole initiated coverage on shares of Petroleo Brasileiro Petrobras SA (NYSE:PBR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) belongs to Basic Materials sector. Its net profit margin is 6.30% and weekly performance is -1.91%. On last trading day company shares ended … Continue reading Trader’s Watch List : Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Intercontinental Exchange, Inc. (NYSE:ICE), Kearny Financial Corp. (NASDAQ:KRNY), Kimberly-Clark Corporation (NYSE:KMB),

Ardelyx Inc (NASDAQ:ARDX) major shareholder Ventures Vii Lp Cmea bought 316,826 shares of Ardelyx stock on the open market in a transaction that occurred on Tuesday, June 24th. The shares were purchased at an average price of $14.00 per share, for a total transaction of $4,435,564.00. Ardelyx Inc (NASDAQ:ARDX) stock performance was 5.14% in last session and finished the day at $20.44. Traded volume was … Continue reading Small Cap Bullish Stocks: Ardelyx (NASDAQ:ARDX), CDI (NYSE:CDI), Alliance Fiber Optic Products (NASDAQ:AFOP), Synta Pharmaceuticals (NASDAQ:SNTA), Fortuna Silver Mines (NYSE:FSM)

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Kovner Bruce purchased 1,250,000 shares of the stock in a transaction that occurred on Friday, April 11th. The shares were purchased at an average cost of $4.01 per share, with a total value of $5,012,500.00. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock performance was 1.01% in last session and finished the day at $4.01. Traded volume was 1.90million shares in the last … Continue reading NASDAQ Recent Insider Buying: Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Equinix Inc (NASDAQ:EQIX), AspenBio Pharma (NASDAQ:APPY)

Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day at $2.60. Traded volume was 16.17million shares in the last … Continue reading Investor’s Alert: Inovio Pharmaceuticals (NYSEMKT:INO), Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Agios Pharmaceuticals (NASDAQ:AGIO)

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced that poster presentations related to studies with ganetespib, a selective Hsp90 inhibitor in clinical development by the company, and the company’s Hsp90 inhibitor drug conjugates (HDC) will be presented at the 2014 Annual Meeting of the American Association of Cancer Research in San Diego, California. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock performance was 10.07% in last session and finished the day … Continue reading Healthcare Bullish Stocks: Synta Pharmaceuticals (NASDAQ:SNTA), TherapeuticsMD Inc (NYSEMKT:TXMD), Cell Therapeutics Inc (NASDAQ:CTIC), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)